More than 480 investigators, students, trainees and faculty presented scientific posters and abstracts at Feinberg’s 16th Annual Lewis Landsberg Research Day.
The first biologic drug to treat moderate-to-severe eczema in infants and children was highly effective in reducing symptoms, according to a recent study.
Therapeutically inhibiting a metabolic regulator in monocytes unexpectedly increased inflammatory signaling, revealing mechanisms that could inform new strategies to treat chronic inflammatory disorders, according to a recent study.
CRISPR pioneer and Nobel Laureate Jennifer Doudna, PhD is the recipient of the inaugural $250,000 Kimberly Prize in Biochemistry and Molecular Genetics.
A two-drug combination has been shown to improve patient response to treatment in relapsed or refractory acute myeloid leukemia.
Amy Paller, MD, the chair of and Walter J. Hamlin Professor of Dermatology, has been named the winner of the 2022 Tripartite Legacy Faculty Prize in Translational Science and Education.
Gen Zers and millennials are approximately two times more likely to be newly diagnosed with high blood pressure during pregnancy, reports a new Northwestern Medicine study.
Investigators have developed a new imaging technique that increases the detection and identification of proteoforms by four-fold when compared to current methods.
Northwestern Medicine investigators continue to study COVID-19, from comparing mortality rates between SARS-CoV-2 variants to examining the effectiveness of maternal vaccination in protecting infants and combating COVID-19 misinformation on social media.
Tobias Holden, a fourth-year student in the Medical Scientist Training Program (MSTP), was lead author of a paper that used mathematical modeling to determine the impact of structural racism and health disparities on COVID-19 mortality rates in Illinois.